1-2 of 2
Filippo Ansaldi
Close
Sort by
Journal Articles

Seasonal and pandemic (A/H1N1 2009) MF-59–adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

Davide Bedognetti, Filippo Ansaldi, Elisa Zanardi, Paolo Durando, Mario Roberto Sertoli, Carlotta Massucco, Enrico Balleari, Omar Racchi, Gabriele Zoppoli, Andrea Orsi, Cristiano Alicino, Giancarlo Icardi, Francesco M. Marincola, Simonetta Zupo, Manlio Ferrarini, Andrea De Maria
Journal: Blood
Blood (2012) 120 (9): 1954–1957.
https://doi.org/10.1182/blood-2012-06-438689
Published: 2012
Journal Articles

Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells.

Davide Bedognetti, MD, Gabriele Zoppoli, MD, Carlotta Massucco, Simonetta Zupo, Mario Roberto Sertoli, MD, Manlio Ferrarini, MD, Elisa Zanardi, MD, Nicoletta Provinciali, MD, Guido Siffredi, MD, Graziano Caltabiano, MD, Riccardo Ghio, MD, Alessio Nencioni, MD, Marco Messina, MD, Omar Racchi, MD, Andrea Bruzzone, MD, Marianna Sabatino, MD, Francesco M. Marincola, MD, Maria Libera Ascierto, Lorenzo Uccellini, Pos Zoltan, PhD, Filippo Ansaldi, Andrea De Maria, MD
Journal: Blood
Blood (2009) 114 (22): 936.
https://doi.org/10.1182/blood.V114.22.936.936
Published: 2009